Table 2.
Licensed vaccines.
| Trade name | Disease | Antigen (s) | Indications | Formulation | Dosage | References |
|---|---|---|---|---|---|---|
| Sabin Live OPV |
Polio | Live-attenuated, trivalent OPV vaccine Sabin strains 1,2,3 |
*Not currently used in US | Solution | Three doses, taken at least four weeks apart | [8,90,92] |
| Vivotif | Typhoid Fever | Live-attenuated strain, Ty21a | Children (N6 years) | Enteric coated capsule | Four, taken on alternate days | [8,89,93–95] |
| Dukoral | Cholera | Recombinant B-subunit and inactivated whole cell Vibrio cholera | N2 years | Suspension | Two doses (75 mL children, 150 mL adults), 1 week apart | [29,98,99,107,109] |
| Vaxchora | Cholera | Live, oral, CVD-10-HgR | Adults (16–64), traveling | Suspension | Single, lyophilized dose reconstituted in 100 mL water | [101,102] |
| Rotarix | Gastroenteritis | Live-attenuated monovalent human rotavirus RIX4414 strain of G1P(8) type |
Infants (6–24 weeks) | Suspension | Two 1 mL doses, 4 weeks apart | [8,103,104] |
| RotaTeq | Gastroenteritis | Attenuated pentavalent live rotavirus reassortants: derived from human and bovine species | Infants (6–32 weeks) | Solution | Three 2 mL doses, 4–10 week intervals | [8,103,104] |
| None | Acute respiratory disease | Adenovirus, live | Military populations (ages 17–50) | Enteric coated tablets | Single dose | [105,106] |